Advancing Diabetes Equity Practice Today (ADEPT 2024)
We are very excited to share that T1D Exchange in collaboration with American Diabetes Association (ADA) will be hosting a new diabetes equity focused conference titled Advancing Diabetes Equity Practice Today (ADEPT). ADEPT 2024 will be held Tuesday and Wednesday, November 12-13 following the T1DX-QI Learning Session 2024 in Chicago, IL.
The conference objectives are to highlight equity best practices and practical strategies on all areas of diabetes, (pre diabetes, type 1, type 2, gestational diabetes, and diabetes in pregnancy). We encourage members to attend and invite your colleagues.
Use this link to view the FAQ. More details coming soon on how to register.
For additional questions please email qi@t1dexchange.org
8th Annual T1D Exchange Learning Session 2024
The T1DX-QI November Learning Session will be held Monday, November 11, in Chicago, IL. The Learning Session will be a 1 day event this year.
Please use this link to view the FAQ. Abstract submissions are now open, please use this link to submit your abstract to share your centers work.
For additional questions please email qi@t1dexchange.org
T1DX-QI Faculty ADA 2024 Breakfast RSVP
If you are attending ADA in Orlando Florida June 21-24 2024, we encourage you join us for T1DX-QI faulty breakfast on Sunday June 23, from 6:30-8am EST. Please use this link to submit your RSVP on or before May 30th. Limited spots are available. Please reach out to qi@t1dexchange.org with any questions.
T1DX-QI Presentations at ADA Scientific Sessions 2024
T1DX-QI is being represented by 5 oral and 9 poster presentations at the 2024 ADA Scientific Sessions, June 21-24 in Orlando Florida. Thank you all for your contributions and for your continued support in improving outcomes for people with diabetes. We are very excited to continue to share the great work of the Collaborative!
Please see the list of accepted topics that will be shared.
329-OR Dynamics of Treatment Regimens and Glycemic Outcomes in >100,000 Children from International Pediatrics Diabetes Registries *Recipient of ADA President Scholar Award
135- OR Examining New-Onset Type 1 Diabetes Educational Practices among Centers in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
ADA Scholars Session: Quality Improvement
CT-SY21-1.5 Improving diabetes outcomes and reducing inequities through collaboration: Perspective from the T1D Exchange
CT-SY25-1 Current Approaches to Addressing Racial Equity—Insights from the T1D Exchange QI Collaborative
1131-P Successful Strategies to Reduce Delays in Quality Data Reporting
1293-P Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among centers participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
1109-P Diabetes Technology Education Processes Among Centers in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
118-P Engaging Data Teams in Electronic Medical Record Data Extraction for Diabetes Real World Data and Improvement Projects
778-P Changes in HbA1c with GLP-1 use in People with Type 1 Diabetes: Data from the T1D Exchange QI Initiative
804-P Understanding Off-Label Use of GLP (Glucagon-Like Peptide-1 Receptor) Agonists among Providers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
959-P Multiple Daily Injection (MDI) to Automated Insulin Delivery (AID) versus non-AID Insulin Pump for newly diagnosed people with Type 1 diabetes offers improvement in glycemic control
1456-P Type 1 diabetes care and device use in older adults: Transatlantic comparison based on T1DX-QI and DPV registries
1939-LB Improving Capacity for Quality Improvement in Type 2 Diabetes Primary Care Centers
Use this link to view all T1DX-QI Publication and Abstracts!
ATTD 2024
T1DX-QI was represented by 1 oral and 1 poster presentation at ATTD 2024.
Oral: Type 1 Diabetes Glycemic Outcomes Are Improving: Real World Data of Over 80,000 People in the T1D Exchange Quality Improvement Collaborative
Poster: Ranking of Factors Considered Important by Diabetes Providers Before Recommending Automate Insulin Delivery Systems
There have been several newly asked questions on the internal member website. Please use this link to respond and see all questions.
New Questions:
Question:
For the pediatric centers: Currently at Cook the diabetes educators take any urgent call from Friday at 5pm-Monday at 8am and will also do inpatient education for newly diagnosed patients. I am trying to change the call portion and wanted to see if anyone had information I can benchmark from. Who is responsible for your weekend and holiday diabetes calls? Do the CDCES, fellow's, endocrinologist, triage nurses (used for PCP or all specialties) take calls? Additionally, how do you handle new onsets on weekends and holidays? Do the diabetes educators perform new onset education on the weekends and holidays? Thank you!
Name: Stephanie Ogburn, BSN, RN, CDCES
Clinic: Cook Children's
Question:
Do your healthcare systems have an opt-in or opt-out option for research contact? For example, at our institution when a patient consents to treatment, they can also opt-in to be contacted for research. But I know some institutions have a policy where once you consent to treatment, you also consent to being contacted about eligible research studies (have to opt-out of being contacted). I am trying to get a sense of the landscape.
Name: Laura Jacobsen, MD
Clinic: University of Florida
Question:
We are curious if other institutions are using concentrated insulin in insulin pumps. And if so, do you have an resources for the team/patients/families to minimize the risk for dosing errors.
Name: Allison Smego, MD
Clinic: Primary Children's Diabetes - Univeristy of Utah/Intermountain
Congratulations!
We would like to congratulate Dr. Mary Pat Gallagher of Dr Mary Pat as Division Director of Pediatric Endocrinology at Hassenfeld Children's Hospital at NYU Langone.
We know that she will be an excellent leader and champion in this new role.
Congratulations Dr. Gallagher on a job well done!
Events & Reminders
Upcoming Opportunities
Here are a few opportunities shared with the Collaborative.
Stanford School of Medicine is inviting Physicians, CDCES and APPs who care for youth with T1D on public insurance to share their experiences. Use this link to view more information.
.png?upscale=true&width=520&upscale=true&name=MicrosoftTeams-image%20(58).png)